Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Summary

This pilot clinical trial studies the side effects and how well cetuximab before surgery works in treating patients with skin cancer that forms, grows, and spreads quickly and has spread from where it started to nearby tissue or lymph nodes. Monoclonal antibodies, such as cetuximab, may block tumor growth in different ways be targeting certain cells. Giving cetuximab before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

Timeline

Start

2015-01-30

Primary completion

2020-12-09

Completion

2023-05-30

Drugs

Indications